Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
Author:
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,Oncology
Link
http://link.springer.com/content/pdf/10.1186/s13014-018-1185-9.pdf
Reference44 articles.
1. De Santis CE, Lin CC, Mariotto AB, Siegel RL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.
2. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8:378–82.3.
3. Wei AC, Greig PD, Grant D, et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13:668–76.12.
4. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18 13.
5. Tomlinson JS, Jarnagin WR, Dematteo RP, et al. Actual 10-yearsurvival after resection of 514 colorectal liver metastases defines cure. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25:4575–80 14.
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Stereotactic body radiation therapy for colorectal cancer liver metastases;Journal of Gastrointestinal Oncology;2024-08
2. Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival time;British Journal of Cancer;2024-05-06
3. Phase I trial of single-photon emission computed tomography–guided liver-directed radiotherapy for patients with low functional liver volume;JNCI Cancer Spectrum;2024-04-30
4. Markerless liver online adaptive stereotactic radiotherapy: feasibility analysis;Physics in Medicine & Biology;2024-04-22
5. Imaging Considerations before and after Liver-Directed Locoregional Treatments for Metastatic Colorectal Cancer;Diagnostics;2024-04-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3